A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease

Clinical trial NCT03056742 · WITHDRAWN

Trial details

NCT number: NCT03056742
Sponsor: Stempeutics Research Pvt Ltd
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia Due to Buerger's Disease

Start date: 2017-02-20
Primary completion: 2018-04-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.